Applied DNA Sciences, a biotechnology company based in Stony Brook, New York, specializes in DNA-based technology solutions and went public in 2001. It offers PCR-based diagnostics for COVID-19 and population-scale testing through its subsidiary, Applied DNA Clinical Labs.
Applied Dna Sciences (APDN) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Applied Dna Sciences's actual EPS was -$0.32, beating the estimate of -$0.35 per share, resulting in a 7.73% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.